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Abstract 
 This study aimed to review the literature about possible physiological 
interactions of calcium and vitamin D in colon. Previous studies have 
indicated to protective effects of vitamin D and calcium in case of colon 
cancers. We wanted to check the physiological effects of both of vitamin D 
and calcium, and either of each of them alone. We suggested effects of 
metabolism through induction of changes in the levels of various biomarkers 
that have influences in carcinogenesis including p53, heat shock proteins, 
iNOS and WT1 gene. 
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Introduction   
 It has become common knowledge that an adequate supply of 
calcium and vitamin D is indispensable for optimal skeletal development as 
well as for maintenance of bone health (Peterlik et al., 2009).  
 However, it is of interest to note that inadequate intake and 
absorption of calcium as well as a compromised vitamin D status are not 
only well-known risk factors for skeletal disorders, but also contribute to the 
infectious, chronic inflammatory and autoimmune diseases (Peterlik and 
Cross, 2005). 
 Vitamin D receptors (VDRs) are present in a large variety of cell 
types including: colonic mucosal cells, and these cells are able to convert 25-
(OH)3 into the active form of vitamin D (1,25-(OH)2 D3) ( Kallay et al., 
2005).  
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 Vitamin D regulates colonic proliferation, differentiation, apoptosis 
and angiogenesis, and the colonic vitamin D system is regulated by several 
known natural factors; the most important once is nutritional calcium (Cross 
et al., 2009)  
 Cell death by apoptosis occurs as a part of a natural regulatory 
process in the body, serving to establish and maintain a proper control of the 
cellular turnover. Tumor suppressor act to maintain tissue homeostasis, that 
is, to control the apoptosis process and p53 protein is the most extensively 
studied tumor suppressor (Hansen et al., 2001; Grorge, 2011). 
 P53 gene has been found to be mutated in more than 50% of human 
cancers; and p53 protein  is a very labile protein, with a short  half-life, but  
it was recently demonstrated that WT1 protein play an important role to alter 
p53 stability (Asher et al.,2001). 
 The ability to maintain O2 homeostasis is essential to survival , so the  
intricately branched circulatory network of vascular endothelial and 
supporting cells is essential for transporting oxygen, nutrients and removal of 
carbon dioxide and metabolic products from cells, tissues and organs; 
formation of new blood vessels is divided into two components: 
vasculogenesis and angiogenesis (Hirota and Semenza, 2006).  
 Vascular epithelial growth factor (VEGF) signaling is required for 
the full execution of vasculogenesis and angiogenesis (Roskoski, 2007). 
Increasing age is associated with a reduced capacity to maintain homeostasis 
in all physiological systems and it might be that this results, in part at least, 
from a parallel and progressive decline in the ability to produce heat shock 
proteins (Pockley, 2001). Heat shock proteins play an important role in 
protein homeostasis, and they found in major cellular compartments 
(Tkacova, 2012). Directly or indirectly, 1, 25 dihydroxyvitamin D controls 
more than 200 genes, include genes responsible for the regulation of cellular 
proliferation, differentiation, apoptosis and angiogenesis (Holick, 2007), but 
the effect of vitamin D with and without calcium was studies only on various 
types of cancer, of these, colon, breast, prostate, renal and ovarian cancer 
(Park et al , 2007; Peterlik et al., 2009; Cui Y. and Rohan T., 2006).  
 Thus no report was made discussing the physiological effects of 
vitamin D and calcium  on colon, and especially their effect on the WT1 and 
P53 level and explains clearly the stability effect of WT1 on p53, the current 
work will be interested in evaluating the physiological activity of vitamin D 
with and without calcium on colon.   
 
The colon 
 The large intestine, or colon , extends from the ileocecal valve to the 
anus, forming the small intestine on three sides, chyme from the ileum passes 
into cecum, at the beginning of the large intestine. Waste material then pass 
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in sequence through the ascending colon, transverse colon, descending colon, 
sigmoid colon, rectum and anal canal (Fox, 2011).  
 
Figure 1. The large intestine. The different regions of the large intestine(colon)(Fox, 2011) 
 
 The colon, has little or no digestive function, but it does absorb water 
and electrolytes from remaining chime, as well as several B complex 
vitamins and vitamin K (Fox, 2011) The colonic mucosa cells are also able 
to convert 25-(OH)3 into the active form of vitamin D (1,25-(OH)2 D3) ( 
Kallay et al., 2005) whereas 25(OH)D3 serum concentration is a major 
determinant of 1,25-(OH)2 D3 synthesis in colonic mucosa, which expresses 
the vitamin D receptor and both the synthesizing (CYP27B1) and catabolic 
(CYP24A1) hydroxylases (Cross and Kallay, 2009). 
  
Calcium 
 Calcium is an important mineral component of our diet. It is chiefly 
available to us in milk and milk products, certain seafood, legumes and some 
vegetables. The name of calcium is derived from Latin word calas, meaning 
lime, was known as early as the first centuries when the ancient Romans 
prepared lime as CaO. It was not actually isolated until 1808 in England 
when Humphrey Davy electrolyzed a mixture of lime and mercuric oxide. 
Davy was trying to isolate calcium along with magnesium, strontium and 
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barium. Out of alkaline earth group, Ca++ has achieved greatest use and 
tonnage (Bhatia, 2008; Pravina et al., 2013). 
 The body contains about 2% of calcium and about 98% of this is in 
the bones which act as a reservoir of calcium for use throughout the body. 
Different levels of daily Ca++ intake according to age and sex. Minimum of 
1,000 mg calcium per day is required for healthy adults until age 60 years, 
while higher values apply for people of advanced age or women during 
pregnancy and lactation as well as after menopause (Fox, 2009; Peterlik et 
al., 2009). 
 
Calcium forms 
 Total Calcium in serum and extracellular fluid is divided into three 
forms: a) ionized form, which comprises approximately 50% of the total; b) 
calcium bound with protein, which represent approximately 45% of the total, 
and c) calcium that is complexed to anions such as citrate, bicarbonate or 
phosphate, this form comprises approximately 5% of the total (Sharan et al., 
2008). 
 The protein- bound calcium does not diffuse out of the blood and it is 
bound principally to negatively- charged sites of albumin with smaller 
amount bound to globulins (Pravina et al., 2013). 
 
Calcium homeostasis 
 The body has a fine tuned system to regulate the level of calcium in 
the extracellular fluid; this system is termed the calcium homeostatic system, 
it involves several hormones and organs. The hormones involved the 
parathyroid hormone, vitamin D and calcitonin. And the organs involved the 
parathyroid gland, kidney, skeleton and intestine (Tfelt, 2008). 
 
Biological activity of calcium 
 Calcium is essential to maintaining total body health; the body needs 
it every day not just to keep bones and teeth strong, it is very important 
extracellularly as well as intracellularly. In the cell Ca++ serves as an 
intracellular messenger that participates in muscle contraction, 
neurotransmission, and enzyme activity; in outside the cell, the extracellular 
calcium ion is important as the cation participates in blood clotting, 
contributes to maintaining the membrane potential across the cell membrane, 
neurotransmitter release, and maintenance skeletal integrity (Shara et al., 
2008; Pravina, 2013). 
 
Vitamin D 
 The term "vitamin D" was first used in 1922 when McCollum and 
colleagues reported the identification of a new lipid- soluble substance, 
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which they named vitamin D. This finding appeared to be of great 
importance as the new vitamin showed to be capable of preventing rickets, a 
bone disease, which at that time had reach epidemic proportion (Hansen et 
al., 2001; Holick, 2006). 
 The identification of vitamin D led to intensive search for the active 
substrate of this vitamin, in 1931 Askew and colleagues succeeded in 
isolating vitamin D2 from irradiated plant sterols, later in 1936, vitamin D3 
was identified by Windaus and colleagues, but it was not until the 
1971where (1, 25(OH)2 D3) the metabolically active form of vitamin D3 
was identified by Holick and colleagues (Holick, 2003; Kochupillai, 2008). 
 
Vitamin D forms  
 There are  two naturally occurring forms of vitamin D are 
cholecalciferol (vitamin D3) that is synthesized in the skin of animals and 
humans in response to sunlight. and ergocalciferol (vitamin D2) that is 
photochemically synthesized in plants (Cui and Rohan, 2006; Vuolo et al., 
2012). 
 Recent studies in humans have provided evidence that vitamin D3 is 
more efficient than vitamin D2 in increasing serum concentration of vitamin 
D and maintaining those levels for a longer time; also its metabolites have 
superior affinity for vitamin D- binding proteins in plasma. (Armas et al., 
2004). 
 1, 25(OH) 2D3 the metabolically active form of vitamin D is 
structurally related to the classic steroid hormones, in contrast to the classic 
steroid hormones, the B-ring of the ring structure has undergone fission by 
breakage of the 9,10 carbon bond and chain and is conformationally more 
flexible than the classic steroid hormones (Hansen et al., 2001). 
   
 
 
 
 
Figure 2: The chemical structure of vitamin D2 and vitamin D3 (Mercier and Luu, 2009). 
Vitamin D2 Vitamin D3 
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Synthesis of Vitamin D  
 Up to 80% of the body’s need for vitamin D3 can be met by UV-B-
induced synthesis of vitamin D3 in the skin (Cross et al., 2009). 
  The precursor of vitamin D3 is synthesized in the skin from 7-
dehydrocholesterol, this is an important molecule in the synthesis of 
cholesterol and is present mainly in the stratum spinosum and stratum basal 
of the epidermis; 7-dehydrocholesterol is a strong UV absorber with 3λ max 
around 290-310 nm, and under UV irradiation it is partly photolysis to create 
previtamin D3, which immediately converted to vitamin D3 in a heat- 
dependent process (Mercier and Luu, 2009). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Chemical structure of 7-dehydrocholesterol (Mercier and Luu, 2009) 
 
 During prolong exposure to the sun; the synthesis of previtamin D3 
reaches a plateau at concentration of about 10-15% of the original 7-
dehydrocholesterol concentration. In turn, previtamin D3 and vitamin D3 
degrade into inactive photoproducts (Holick et al., 2011).  
 Vitamin D is poorly soluble in aqueous media and highly soluble in 
lipids, therefore it is transported in blood with the help of a binding carrier 
protein called vitamin D binding protein (DBP), plasma concentration of 
DBP is 20 times higher than the total amount of vitamin D 
metabolites.(Kochupillai, 2008) 
 After the synthesis of vitamin D in the skin from 7- 
dehydrocholesterol or by intestine absorption of vitamin D2 from the dietary 
sources, the vitamin D is transported by DBP to adipose tissues for storage 
and for the liver where it is hydroxylated by the mitochondrial cytochrome 
P450 enzyme, 25-hydroxylase (CYP27A1), to 25- hydroxyvitamin D3 
(25(OH) D3) which is the major circulating form of vitamin D. The 
production of 25(OH) D3 is virtually uncontrolled and seems to correlate 
with substrate availability rather than with physiological needs. Therefore, 
measuring circulating 25(OH) D3 levels provides a useful indicator of the 
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actual vitamin D status in the body and is widely applied in clinical practice 
(Hansen et al., 2001; Kallay et al., 2005; Lee et al., 2008). 
 Because 25(OH) D3 is biologically rather inactive, it has to be 
converted by C1α-hydroxylation to the hormonally active metabolite, 1, 25-
dihydroxyvitamin D3 (1, 25(OH)2 D3) also called Calcitriol. This occurs 
primarily in proximal tubule cells of the kidney catalyzed by another 
cytochrome P45 enzyme, 1α- hydrolase (CYP27B1). (Holick, 2007; Cross et 
al., 2009). Although, other tissues and cell types have been shown to contain 
CYP27B1 and to produce 1, 25(OH)2 D3 from 25(OH) D3, the kidney is 
supposed to be the major site of production of circulating 1, 25(OH)2 D3, 
and in contrast to hepatic production of  25(OH) D3, renal synthesis of 1, 
25(OH)2 D3 is a strictly regulated process that responds to the physiological 
needs for calcium and phosphate. Several agents have been suggested to be 
involved in this regulated, including protein kinase C (PKC), estrogens, 
prolactin, calcitonin and glucogorticoids, but the two most important 
physiological regulators are 1, 25(OH)2 D3 itself and parathyroid 
hormone(PTH) (Hansen et al ., 2001; Holick, 2006;    Holick and chen, 
2008).. 
 
Figure 4: synthesis steps of 1, 25- dihydroxyvitamin D3 
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Biological activity of vitamin D 
 The traditionally recognized role of vitamin D consist in the 
regulation of bone metabolism and calcium-phosphorus homeostasis, 
Besides these classic action , vitamin D3 has been shown to exert potent 
regulatory effects on growth and differentiation in a variety of cells which 
are not directly involved in the calcium metabolism ( Vuolo et al., 2012). An 
adequate supply of vitamin D is necessary to protect against several chronic 
diseases, such as rickets in children and osteoporosis in adult (Holick, 2006) 
hypertension, cardiovascular disease (Vacek et al., 2012). diabetes mellitus, 
allergic disorder, immunological disorder (Holick and Chen, 2008) and 
secondary hyperparathyroidism (Gonz et al., 2013). 
 
Role of vitamin D in calcium homeostasis 
 1, 25(OH)2 D3 is the biologically active form of vitamin D 
responsible for maintaining 
 calcium and phosphorus homeostasis. It enhances the efficacy of 
small intestine to absorb calcium and phosphorus; it accomplishes this by 
interacting with its nuclear receptor, the vitamin D receptor (VDR) in the 
small intestinal cells (Fox, 2011). 
 The 1, 25(OH)2 D3 –VDR structure complexes with retinoic acid X 
receptor (RXR) in the nucleus. The1, 25(OH)2 D-VDR-RXR complex binds 
to the vitamin D–responsive element (VDRE) for the epithelial calcium 
channel. The increased expression of the calcium channel permits more 
calcium to enter the cell, where the vitamin D–dependent calcium-binding 
protein calbindin 9K helps calcium’s translocation into the bloodstream 
(Holick, 2006; Kochupillai, 2008). 
 When dietary calcium is inadequate, vitamin D helps maintain 
calcium homeostasis by interacting with the VDR in osteoblasts to induce 
the expression of the plasma membrane protein receptor activator of NF-κB 
ligand (RANKL). The RANK on the plasma membrane of preosteoclasts 
binds RANKL, which induces the preosteoclast to become a mature 
osteoclast; the mature osteoclast releases hydrochloric acid and collagenases 
to dissolve bone and release its precious calcium and phosphorus stores into 
the circulation (Holick, 2006; Holick, 2007). Apoptosis 
 Apoptosis is a type of physiological cell death that occurs during 
development normal tissue or as a result of different cellular insults (Hansen 
et al., 2001). 
 The term "apoptosis" was introduced by Kerr and his colleagues in 
1971 to describe the morphological changes of this characteristic form of cell 
death; these changes involve chromatin condensation, cytoplasmatic and 
nuclear blabbing, eventually cellular demise without loss of membrane 
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integrity and digestion of the resulting small vesicles by macrophages 
(Maximov and Maximov, 2008). 
 Apoptosis is triggered by a number of factors which act as through 
two major apoptotic pathways: extrinsic and intrinsic pathway; both 
pathways are activated by tumor-suppressor p53 protein (Fridman and Lowe, 
2003).  
 These factors include some particular receptors on the cell surface 
(referred to as “death” receptors) and the components of extrinsic and 
intrinsic pathways, regulated by the members of a family of proteins called 
Bcl-2 (promoting mitochondria changes with release of cytochrome-c) 
Whichever pathway is induced, both lead to activation of the members of 
highly selective proteases referred to as “caspases”. That is why the extrinsic 
pathway is otherwise known as the “death receptor pathway” and the 
intrinsic pathway -as the “mitochondrial pathway” (Bai and Zhu, 2006; 
Maximov and Maximov, 2008). 
 
The p53 protein 
 Tumor suppressor p53 protein, also known as "TP53"(tumor protein) 
is a product of the tumor suppressor gene p53 located at the short arm of the 
human chromosome 17; the name is due to its molecular mass: it runs as a 53 
kDa (kilo Dalton) protein (Maximov and Maximov, 2008). 
 The tumor suppressor p53 is a transcription factor involved in 
maintaining genomic integrity by controlling cell cycle and cell survival 
(Somasundaram and Deiry, 2000), p53 is a very labile protein, with a half-
life of about 20 minutes, The rapid degradation of p53 is largely achieved 
through the ubiquitin proteasome pathway. the accumulation of p53 in 
response to DNA damage and other types of stress occurs mainly through 
posttranslational modification Proteins known to alter p53 stability include 
HPV16-E6. simian virus 40 (SV40) large T antigen  adenovirus  
E1ByE4orf6 , WT1, and Mdm2 .Whereas association of SV40 T antigen or 
WT1 with p53 increases p53 stability (Asher et al., 2001).   
 On cellular stress; particularly that induced by DNA damage, p53 can 
arrest cell cycle progression, thus, allowing the DNA to be repaired or it can 
lead to apoptosis  (Fridman and Lowe, 2003).   
 These functions are achieved, in part, by the transactivation 
properties of p53, which activate a series of genes involved in cell cycle 
regulation, in cancer cells that bear a mutant p53, so this protein is no longer 
able to control cell proliferation, which results in inefficient DNA repair and 
the emergence of genetically unstable cells (Soussi, 2000). 
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Angiogenesis 
 Angiogenesis is a complex process that involved the activation, 
proliferation, and directed migration of endothelial cells to form new 
capillaries from existing blood vessels (Oklu et al., 2010).  
 Angiogenesis is absolutely essential for embryonic growth, tissues 
growth and repair, an imbalance in this process contributes to numerous 
malignant, inflammatory, ischaemic, infectious and immune disorders 
(Carmeliet, 2005).  
 The rate of this process is increased during wound healing and tissue 
repair, during ovarian corpus luteum formation, and during placental 
development establishing pregnancy (Roskoski, 2007). 
 This process is regulated by both endogenous activators and 
inhibitors, and this regulate is under stringent control, there are about 30 
known endogenous pro-angiogenic factors. The VEGF/FEGFR (vascular 
endothelial growth factor/VEGF receptor) family is the most studies 
regulators of vascular development (Plank and Sleeman, 2003). 
 
Vascular endothelial growth factor (VEGF) 
 VEGF is an essential regulator of angiogenesis process; the three key 
activators of endothelial cell in angiogenesis are secretion of proteases, 
migration and proliferation. VEGF is capable of inducing all three of these 
(Oklu et al., 2010).  
 The VEGF family consists of six members: VEGF-A, VEGF-B, 
VEGF-C, VEGF-D, VEGF-E, and placental growth factor (PlGF). VEGF is 
so potent an angiogenesis activator that its expression must be precisely 
controlled both spatially and temporally for angiogenesis to proceed 
correctly (Plank and Sleeman, 2003).  
 There are three receptors protein-tyrosine kinase for VEGF family of 
ligands (VEGFR1, VEGFR2 and VEGFR3) and two non-enzymatic 
receptors (neuropilin-1 and -2) (Roskoski, 2007). 
 
Heat shock protein 
 Heat shock proteins (HSPs) are a large class of proteins that have 
been conserved throughout evolution and exist by prokaryote and eukaryote 
organisms, they play an important role in protein homeostasis, they are 
synthesized as a response to a number of factors, for example, elevated 
temperature, UV radiation, bacterial and viral infection, heavy metal and 
others (Latchman, 2003; Tkacova and Angelovicova, 2012). 
 Many of these proteins are synthesized by normal unstressed cells 
with their synthesis being further enhanced upon exposure to stress, for 
example hsp90 is one of the most abundant proteins in unstressed cells 
(Pockley, 2001). 
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 HSPs are categories into several families that are named on the basis 
of their approximate molecular mass (the 70 kDa Hsp70, 60kDa Hsp70 and 
90 kDa Hsp 90) under physiological conditions, some of these proteins 
function as molecular chaperones or proteases that have a number of 
intracellular functions(Latchman, 2003).  
 Chaperones regulate changes in the protein arrangement through 
membrane during transport, they regulate conformation- arrangement of 
protein at the slight damage, chaperones inhibit of change of proteins 
conformation at increased temperature to 42˚C in the cell, both in normal and 
in stressed cells there will be a need to degrade proteins  which have become 
abnormally folded and cannot be rescued by the action of chaperone 
proteins, it is therefore of interest that proteases such as the ubiquitin-
dependent proteasome which plays a critical role in protein turnover by 
being linked to proteins marked for degradation (Latchman, 2003; Tkacova 
and Angelovicova, 2012). 
 
The Wilms’-Tumor suppressor protein (WT1) 
 The Wilms’- tumor suppressor gene WT1 was originally identified as 
a tumour suppressor involved in the formation of Wilms’ tumour of the 
kidney, and was additionally found to be associated with genitourinary 
disorders such as Denys Drash and Frasier syndromes ( Hartkamp and 
Roberts, 2008; Ohno et al., 2009). 
 The biology of WT1 is complex, since in addition to its function as a 
tumour suppressor; this gene has multiple roles during development and 
maintenance of body function (Wagner et al., 2003). 
 This gene encodes a zinc finger transcription factor (Wilms’- Tumor 
"WT1") that plays important roles in cell growth and differentiation 
.Although WT1 gene was categorized at first as a tumor-suppressor gene, it 
was recently demonstrated that the wild type WT1 gene has also emerged as 
an oncogenic factor influencing proliferation and apoptosis in a large variety 
of adult cancers (Hohenstein and Hastie, 2006; Ohno et al., 2009). 
 WT1 is expressed during mammalian embryonic development in 
many tissues, and the complexity of WT1 action during development is 
reflected on the molecular level. Post-transcriptional modifications of the 
Wt1 pre-mRNA lead to the production of up to 24 different isoforms, may 
result from a combination of alternative translation start sites, alternative 
RNA splicing and RNA editing, which seem to serve distinct but also 
overlapping cellular and developmental functions (Wagner et al., 2003; 
Hohenstein and Hastie, 2006). 
 It is now well established that WT1 can bind, via its zinc fingers, to 
the promoter regions of > 20 downstream target genes, and the effects of 
WT1 on transcription can be either repressing or activating, depending on the 
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cell type and the target gene with which WT1 interacts (Mrowka and Schedl, 
2000). 
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